Recent GuestsSearch:  

Matthew Walsh
Matthew Walsh

Chief Operating Officer
Geisinger Health
https://www.geisinger.org/

Matthew M. Walsh, Chief Operating Officer, Clinical Enterprise, joined Geisinger Health in April 2017. In his role, he serves as a key leader in implementing Geisinger’s strategic plan. He is responsible for planning, organizing, integrating and continually improving day-to-day operations and outcome management across the Clinical Enterprise, supply chain and facilities support services.

Matt has more than 13 years of combined operational, clinical and administrative expertise with the Henry Ford Health System (HFHS), the Henry Ford Medical Group (HFMG) and Health Alliance Plan (HAP). As Senior Vice President/Chief Operating Officer of HAP, he worked effectively with diverse stakeholders including physicians and health system leaders, Michigan companies, and Information Technology (IT) teams to uphold high standards of service excellence and enhance the overall customer experience. Matt had responsibility for IT, enrollment & billing, claims processing, customer service, facili(Show Full Bio)ties, and business transformation. He led HAP’s ReThink program focused on transforming to a LEAN culture, which improved operational efficiency, quality, customer service, and employee engagement. He also led the successful merger of HAP and HealthPlus.

Prior to becoming the SVP/COO of HAP, Matt served as the Chief Access Officer for the HFMG and was responsible for improving patient access across 26 ambulatory clinics and call centers. Key outcomes achieved include a reduction in appointment lead times, significantly improved call center performance metrics and PressGaney patient access satisfaction scores. Concurrent with that role, Matt was the HFHS Vice President of Clinical Transformation and IT Integration, co-leading the complex implementation of Epic’s electronic medical record and billing system across seven hospitals, the HFMG and its ambulatory sites, and independent physician practices. This effort created one patient medical record across all HFHS sites of care and enabled significant system integration.

Deeply committed to the community, Matt served on the boards of the Detroit Metropolitan YMCA, American Diabetes Association, and Focus: HOPE. He received his bachelor’s degree in Business Administration from the University of Michigan and his masters’ degree in Healthcare Administration from the University of Phoenix.

Episode: 2/27/2018 @12:00 PM


Brandon Carrus
Brandon Carrus

Senior Partner
McKinsey & Company
https://healthcare.mckinsey.com/

Brandon Carrus is a Partner in McKinsey & Company. Brandon is the leader of the Healthcare Systems/Services Operations practice in the Americas. The practice focuses on serving the leading healthcare organizations on topics of operations performance transformation, operations and technology strategy, infrastructure development, Lean Management, and capability building. A lean practitioner for over 20 years, Brandon has developed tailored approaches to improving quality, service and customer experience in healthcare.

Brandon holds a Masters of Science and Bachelor of Science in Mechanical Engineering from the Massachusetts Institute of Technology and is a published author in the field of hospital operations and manufacturing implementation techniques. Prior to McKinsey, Brandon worked as a mechanical engineer with high tech and industrial organizations, with a focus on lean manufacturing transformations, and has additional work experience in product and process design engineer(Show Full Bio)ing.

Episode: 2/27/2018 @12:00 PM


Dr. Robert Vonderheide
Dr. Robert Vonderheide

Abramson Cancer Center Director
Abramson Cancer Center of the University of Pennsylvania
https://www.pennmedicine.org/cancer

Robert H. Vonderheide, MD, DPhil is director of the Abramson Cancer Center of the University of Pennsylvania and the John H. Glick MD Abramson Cancer Center's Professor in Penn's Perelman School of Medicine. Dr. Vonderheide also serves as a member of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania and an investigator in Penn's Basser Center for BRCA, the world's first center devoted to the study of BRCA-related cancers.

Dr. Vonderheide graduated from Oxford University as a Rhodes Scholar, and Harvard Medical School. He completed training in internal medicine and medical oncology at the Massachusetts General Hospital and the Dana Farber Cancer Institute. Dr. Vonderheide is a distinguished scientist and clinician who has deciphered mechanisms of cancer immune surveillance and developed novel cancer immunotherapy, particularly in pancreatic cancer. He is well-recognized for driving the development of agonist CD40 antibodies, now in later stage clinic(Show Full Bio)al trials as potential immune therapy of cancer.

Dr. Vonderheide discovered telomerase as a universal tumor antigen recognized by cytotoxic T cells and has led the efforts to develop telomerase vaccination for both therapy and, most provocatively, the prevention of cancer in healthy individuals. More recently, he has shown that stereotactic radiation therapy in combination with dual checkpoint blockade represents a synergistic path for immune activation in cancer. In each area, Dr. Vonderheide merges his clinical investigations with rigorous studies in mouse models or other laboratory systems. His high-impact findings have been published in Nature, Science, Cell and the New England Journal of Medicine.

Twitter - @PennCancer

Episode: 2/13/2018 @12:00 PM


Dr. Gerald Linette
Dr. Gerald Linette

Chief Medical Officer for Cancer Immunotherapy
Abramson Cancer Center of the University of Pennsylvania
https://www.pennmedicine.org/cancer

Gerald P. Linette, MD, Ph.D., is a graduate of the Medical Scientist Training Program, Georgetown University School of Medicine. He completed training in Internal Medicine and Molecular Oncology at Washington University in St. Louis followed by a fellowship in Hematology-Oncology at Massachusetts General Hospital/DFCI. Dr. Linette is currently a Professor of Medicine in the division of Hematology-Oncology and Medical Director of the Sean Parker Institute of Cancer Immunotherapy in the Perelman School of Medicine at the University of Pennsylvania.

His primary interest is the development of cellular immunotherapies for melanoma and other solid tumors. His laboratory research is focused on human tumor neoantigen discovery. Dr. Linette is board certified in Internal Medicine and Medical Oncology and he maintains an active clinical practice at the University of Pennsylvania Abramson Cancer Center.

Twitter - @PennMedicine

Episode: 2/13/2018 @12:00 PM


Dr. John Wherry
Dr. John Wherry

Professor of Microbiology
Abramson Cancer Center of the University of Pennsylvania
https://www.pennmedicine.org/cancer

E. John Wherry, Ph.D., is the Richard and Barbara Schiffrin President's Distinguished Professor of Microbiology and director of the Institute for Immunology at Penn. The Institute was established in 2009 to provide an administrative and programmatic structure to unify the basic, translational, and clinical immunology communities across the University. He is also the co-director of the Parker Institute of Cancer Immunotherapy at Penn. Wherry's research focuses on T-cell memory, host-pathogen interactions, and immunity to persisting infections in model systems and in humans. In particular, his laboratory has been at the forefront of defining the molecular and regulatory control of T-cell exhaustion and immune dysfunction that occurs during chronic infections and cancer. He has been recognized as one of the most highly cited investigators in his field by Thomson/ISI, as one of America's Young Innovators by Smithsonian magazine and serves on numerous scientific advisory panels and editoria(Show Full Bio)l boards including The Journal of Experimental Medicine, PLoS Pathogens, The Journal of Immunology and The Journal of Leukocyte Biology.

Twitter - @EJohnWherry

Episode: 2/13/2018 @12:00 PM


Christina Farr
Christina Farr

Technology Reporter
CNBC.com
https://www.cnbc.com/christina-farr/

Christina Farr is a technology and health reporter for CNBC.com in San Francisco. She most recently was a senior writer at Fast Company, covering biotech and health-tech for digital and print, and an Apple reporter at Reuters News. She hails from London, UK and is a graduate of Stanford's School of Journalism.

Twitter - @chrissyfarr

Episodes: 2/6/2018 @8:00 PM, 10/10/2017 @12:00 PM, 8/8/2017 @12:00 PM


Electra Paskett
Electra Paskett

Director of the Center for Cancer Health Equity
James Cancer Hospital
https://cancer.osu.edu/

Electra D. Paskett, Ph.D., became the Marion N. Rowley Professor of Cancer Research at The Ohio State University in 2002. She is the Director of the Division of Cancer Prevention and Control in the College of Medicine, a professor in the Division of Epidemiology in the College of Public Health and the Associate Director for Population Sciences and Program Leader of the Cancer Control Program in the Comprehensive Cancer Center of the Ohio State University (OSU). She is also Director of the Center for Cancer Health Equity at the James Cancer Hospital. Dr. Paskett’s research program is nationally recognized for studying cancer health disparities. The program has four major areas of focus and has evolved to utilize a "team science approach" to understanding and intervening in these problems: energy balance and cancer prevention; promoting the use of early-detection exams; improving access to diagnostic and treatment services; and lymphedema prevention.

Twitter - @OSUCCC_James

Episode: 2/6/2018 @7:00 PM


Dixon Thayer
Dixon Thayer

Founding Partner
HealthNEXT; Medovation Capital Resources
http://www.healthnext.com

Dixon has over thirty years’ experience in direct leadership of executive & line management in large & small organizations, in the U.S and abroad. His areas of expertise are breakthrough growth strategies, connecting ventures with capital, developing high performance teams, and tangible value creation. He has led the financing, acquisition and integration of several businesses, and a number of significant divestitures / exits as well.
He is an Executive Advisor to Bryant Park Capital, a mid-market investment banking firm; and is a Senior Fellow at the Jefferson School for Population Health (Jefferson University); while also serving as Vice President of the Kieve Wavus Education Foundation Board of Trustees
Dixon has written a number of articles and lectured on topics including “Teaching Elephants to Dance”, “Paradox Navigation”, and “Creating Value & Distinctiveness in Commodity Based Industries”.
Dixon received his degree in Economics from the Wharton School of Business,(Show Full Bio) University of Pennsylvania. He is also a Senior Fellow of Jefferson University’s School of Population Health.

Episodes: 1/30/2018 @12:00 PM, 11/28/2017 @12:00 PM


Steven Krein
Steven Krein

Co-Founder & CEO
StartUp Health
http://startuphealth.com

Steven Krein is the CEO and co-founder of StartUp Health, which is organizing and supporting a global army of Health Transformers. StartUp Health has the world’s largest digital health portfolio at nearly 200 companies spanning 18 countries and 65+ cities.

Prior to StartUp Health, Steven co-founded and led several technology companies including OrganizedWisdom, Promotions.com and Webstakes, a global online advertising, direct marketing, and technology company, which he took public on Nasdaq and grew to a $500M market cap before it was acquired by iVillage in 2002. Steven began his online career with Law Journal Extra!, now known as Law.com, the first online legal news and information website.

Steven is a serial entrepreneur, speaker, investor, advisor and entrepreneurial coach. Steven has been a keynote speaker at events hosted by Children’s Hospital Colorado, Cleveland Clinic, Google, Johnson & Johnson, Lake Nona Institute, McKinsey, Slush and Wharton, among others and (Show Full Bio)has been a guest on Bloomberg TV, CNBC, CNN, FOX Business and The Today Show.

Steven received his JD degree from Delaware Law School and BA degree from the University of Maryland, College Park. Steven is a member of YPO (Young Presidents’ Organization) Metro New York Chapter and lives in New York City with his wife and three daughters. Follow him on Twitter @stevenkrein.

Twitter - @StevenKrein; @StartUpHealth

Episodes: 1/30/2018 @12:00 PM, 11/28/2017 @12:00 PM, 9/5/2017 @12:00 PM, 6/6/2017 @12:00 PM


Martin Gaynor
Martin Gaynor

E.J. Barone University Professor of Economics
Carnegie Mellon University
http://www.heinz.cmu.edu

Martin Gaynor is the E.J. Barone University Professor of Economics and Public Policy at Carnegie Mellon University and former Director of the Bureau of Economics at the U.S. Federal Trade Commission. He is one of the founders of the Health Care Cost Institute, an independent non-partisan nonprofit dedicated to advancing knowledge about US health care spending, and served as the first Chair of its governing board. He is also an elected member of the National Academy of Medicine and of the National Academy of Social Insurance, a Research Associate at the National Bureau of Economic Research, an International Research Fellow at the University of Bristol, and a board member of the Jewish Healthcare Foundation. Prior to coming to Carnegie Mellon Dr. Gaynor held faculty appointments at Johns Hopkins and a number of other universities. He has been an invited visitor at the Hungarian Academy of Sciences in Budapest, the Hebrew University of Jerusalem, Northwestern University, and the Toulouse (Show Full Bio)School of Economics.

His research focuses on competition and antitrust policy in health care markets. He has written extensively on this topic, testified before Congress, and advised the governments of the Netherlands, the United Kingdom, and South Africa on competition issues in health care. Gaynor is on the Pennsylvania Governor's Health Advisory Board and co-chaired the state's workgroup on shoppable care. He has won a number of awards for his research, including the American Economic Journal: Economic Policy Best Paper Award, the Victor R. Fuchs Research Award, the National Institute for Health Care Management Foundation Health Care Research Award, the Kenneth J. Arrow Award, the Jerry S. Cohen Award for Antitrust Scholarship (finalist), and a Robert Wood Johnson Foundation Investigator Award in Health Policy Research. Dr. Gaynor received his B.A. from the University of California, San Diego in 1977 and his Ph.D. from Northwestern University in 1983.

Twitter - @MartinSGaynor

Episode: 1/23/2018 @12:00 PM


Alan Silver
Alan Silver

Director, Actuarial and Financial Strategies; Health Care Consultant
Willis Towers Watson
http://www.willistowerswatson.com

Alan Silver is a Senior Consulting Actuary in Willis Towers Watson’s Benefits Delivery and Administration practice with over 17 years of consulting experience. Throughout his career, Alan has consulted employers on many aspects of employee and retiree health and welfare benefits, including account-based health plan design, pricing and strategy, as well as financial analysis and design of self-insured and insured group programs.

Alan’s technical background combined with his client experience, frequent speaking engagements, and broader public industry exposure has led him to become a nationally recognized subject-matter expert in the areas of retiree medical and healthcare marketplace consulting.

Currently, as a Director of Actuarial and Financial Strategies and Carrier Partnerships in Willis Towers Watson's marketplace business, Alan is responsible for transitioning employers into a marketplace solution - leveraging his relationships with carrier partners and his technic(Show Full Bio)al background to ensure a positive experience for employers and their plan participants.

Alan received a BA in Quantitative Economics with minor concentrations in Mathematics and Philosophy in 2000 from Tufts University. He is an Associate in the Society of Actuaries, a Member of the American Academy of Actuaries, and a Fellow in the Conference of Consulting Actuaries

Episode: 1/23/2018 @12:00 PM


Kenneth Thrope
Kenneth Thrope

Robert W Woodruff Professor and Chair
Rollins School of Public Health, Emory University
http://www.emory.edu

Kenneth E. Thorpe, Ph.D., is the Robert W. Woodruff Professor and Chair of the Department of Health Policy & Management, in the Rollins School of Public Health of Emory University, Atlanta, Georgia. He was the Vanselow Professor of Health Policy and Director, Institute for Health Services Research at Tulane University. He was previously Professor of Health Policy and Administration at the University of North Carolina at Chapel Hill; an Associate Professor and Director of the Program on Health Care Financing and Insurance at the Harvard University School of Public Health and Assistant Professor of Public Policy and Public Health at Columbia University. Dr. Thorpe has also held Visiting Faculty positions at Pepperdine University and Duke University. Dr. Thorpe was Deputy Assistant Secretary for Health Policy in the U.S. Department of Health and Human Services from 1993 to 1995. In this capacity, he coordinated all financial estimates and program impacts of President Clinton’s health car(Show Full Bio)e reform proposals for the White House. He also directed the administration’s estimation efforts in dealing with Congressional health care reform proposals during the 103rd and 104th sessions of Congress.

As an academic, he has testified before several committees in the U.S. Senate and House on health care reform and insurance issues. In 1991, Dr. Thorpe was awarded the Young Investigator Award presented to the most promising health services researcher in the country under age 40 by the Association for Health Services Research. He also received the Hettleman Award for academic and scholarly research at the University of North Carolina and was provided an “Up and Comers” award by Modern Healthcare. Dr. Thorpe was awarded the annual Excellence in Patient Care prize from the National Association of Chain Drug Stores in 2014. He also received the 2012 Champions for Healthy Living Award presented by the YMCA of the USA.

Dr. Thorpe has authored and co-authored over 120 articles, book chapters and books and is a frequent national presenter on issues of health care financing, insurance and health care reform at health care conferences, television and the media. He has worked with several groups (including the American College of Physicians, American Hospital Association, NationalCoalition on Health Care, Blue Cross and Blue Shield Association, Service Employees International Union, AHIP and the United Hospital Fund) and policymakers (including Senators Wellstone, Corzine, Bingaman, Snowe, Feinstein, Cassidy, Carper, Clinton, Obama and Kennedy) to develop and evaluate alternative approaches for providing health insurance to the uninsured. He serves as areviewer on several health care journals.

Dr. Thorpe is chairman, Partnership to Fight Chronic Disease, an international coalition of over 80 groups focused on highlighting the key role that chronic disease plays in the growth in healthcare spending, and the high rates of morbidity and mortality. PFCD focuses as well on identifying best practice prevention and care coordination strategies and scaling them countrywide. He also serves as co-chair of the Partnership for the Future of Medicare, a non-partisan organization focused on identifying long-term reforms that would make the program more efficient and improve the quality of care provided to beneficiaries.

EDUCATION
BA, 1978, University of Michigan
MA, 1980, Duke University
PhD, 1985, Rand Graduate Institute

Episode: 1/16/2018 @12:00 PM


Dr. H. Gilbert Welch
Dr. H. Gilbert Welch

Professor
The Dartmouth Institute
http://tdi.dartmouth.edu/

Dr. Welch is a general internist and professor of Medicine at the Dartmouth Institute for Health Policy and Clinical Research in the Geisel School of Medicine. He is also a professor of Public Policy at Dartmouth College and a professor of Business Administration at the Amos Tuck School.

For the 25 years he has been practicing medicine, Dr. Welch has been asking hard questions about his profession. His arguments are frequently counter-intuitive, even heretical, yet have regularly appeared in the country's most prestigious medical journals — Annals of Internal Medicine, Journal of the American Medical Association, the New England Journal of Medicine and the Journal of the National Cancer Institute — as well as in op-eds in the Los Angeles Times and the New York Times.

He is the author of 3 books – each expanding on the argument of the one before it. Should I be tested for cancer? Maybe not and here's why (2004) deals with the narrow question of early cancer diagnosis. Ov(Show Full Bio)erdiagnosed: Making people sick in the pursuit of health (2011) expands the discussion to include the early diagnosis of any disorder. His newest book “Less Medicine, More Health – 7 Assumptions that Drive Too Much Medical Care" (2015) expands the discussion explore other ways that too much medical care can cause harm – and is intended to be more approachable for general readers.

Dr. Welch is very much part of the “Dartmouth School” that questions the assumption that more medical care is always better. His research has focused on the assumption as it relates to diagnosis: that the best strategy to keep people healthy is early diagnosis – and the earlier the better. He has delineated the side-effects of this strategy: physicians test too often, treat too aggressively and tell too many people that they are sick. Much of his work has focused on overdiagnosis in cancer screening: in particular, screening for melanoma, thyroid, lung, breast and prostate cancer.

Twitter - @DartmouthInst

Episode: 1/16/2018 @12:00 PM


Joseph Dieleman
Joseph Dieleman

Assistant Professor, Institute for Health Metrics and Evaluation (IHME)
University of Washington
http://www.healthdata.org/about/joseph-dieleman

Joseph Dieleman, PhD, is an Assistant Professor at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. In this role, he leads the Financial Resources for Health research team, which focuses on tracking development assistance for health, health expenditure by disease, and government health expenditure. In addition to these activities, Dr. Dieleman works on projects related to non-communicable diseases and understanding the divergent trends in women’s life expectancy in the United States.

Dr. Dieleman studied at Calvin College in Grand Rapids, Michigan, earning his undergraduate degree in Economics, and at the University of Washington, where he received his PhD in Economics. He has also spent time living and working in Tegucigalpa, Honduras.

IHME was established at the University of Washington in Seattle in 2007. Its mission is to improve health through better health evidence.

Episode: 1/16/2018 @12:00 PM


Dr. Mark Pauly
Dr. Mark Pauly

Professor of Health Care Management, Professor of Business Economics and Public Policy
Wharton School of Business, University of Pennsylvania
https://hcmg.wharton.upenn.edu/profile/1518/

Mark V. Pauly currently holds the position of Bendheim Professor in the Department of Health Care Systems at the Wharton School of the University of Pennsylvania. He is Professor of Health Care Systems, Insurance and Risk Management, and Business and Public Policy at the Wharton School and Professor of Economics in the School of Arts and Sciences at the University of Pennsylvania.

One of the nation’s leading health economists, Dr. Pauly has made significant contributions to the fields of medical economics and health insurance. His classic study on the economics of moral hazard was the first to point out how health insurance coverage may affect patients’ use of medical services.

Mark has been actively evaluating a number of the value based reimbursement models and his insights today should be rather informative.

Episodes: 1/9/2018 @12:00 PM, 5/2/2017 @12:30 PM, 12/6/2016 @12:00 PM, 9/27/2016 @12:00 PM


Tom Robinson
Tom Robinson

Partner
Oliver Wyman
http://www.oliverwyman.com

Tom is a Partner in Oliver Wyman’s Health and Life Sciences practice. Tom advises insurers, provider systems, employers and enablement organizations on growth strategies. An engineer by training and a general aviation pilot, Tom brings a quantitative and pragmatic focus to setting strategy and is a trusted adviser to senior executives on topics spanning strategic planning, organizational design and reengineering, financial optimization, and the launch of new businesses.

Tom is a regular industry speaker, has been quoted in publications such as the New York Times, and has developed numerous Oliver Wyman perspectives including, “Economic Capital: A Strategic Tool for Health Insurers,” “Relationship Quiz: Ready to Take the Plunge Into Multi-Year Guarantees?”, “The new age of payer-provider partnerships,” “Claims, it’s a people business” and, “A Billion-Dollar Decision: Charting A New Course for U.S. Healthcare Benefits”

Tom holds a Master of Arts and Master of Engineering f(Show Full Bio)rom Cambridge University. Tom lives in the San Francisco Bay Area with his wife, Ann, and their four children

Episode: 1/9/2018 @12:00 PM


Stanley M. Bergman
Stanley M. Bergman

Chairman of the Board & Chief Executive Officer
Henry Schein, Inc.
http://www.henryschein.com

Since 1989, Stanley M. Bergman has been Chairman of the Board and CEO of Henry Schein, Inc., a Fortune 500® company and the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, with more than 21,000 Team Schein Members and operations or affiliates in 32 countries. Henry Schein is a member of the S&P 500® and Nasdaq 100® indexes. In 2016, the Company's sales reached a record $11.6 billion. Henry Schein has been a Fortune World's Most Admired Company for 16 consecutive years.

Mr. Bergman serves as a board member or advisor for numerous institutions, including New York University College of Dentistry, the University of Pennsylvania School of Dental Medicine, the Columbia University Medical Center, University of the People, Hebrew University, Tel Aviv University, the University of the Witwatersrand Fund, The World Economic Forum's Health Care Governors, the Business Council for International Understanding, th(Show Full Bio)e Japan Society, and the Metropolitan Opera.

Mr. Bergman is an honorary member of the American Dental Association and the Alpha Omega International Dental Fraternity. He is the recipient of the Ellis Island Medal of Honor; the CR Magazine Corporate Responsibility Lifetime Achievement Award; the 2017 CEO of the Year award by Chief Executive Magazine; Honorary Doctorates from The University of the Witwatersrand, Hofstra University, A.T. Still University's Arizona School of Dentistry and Oral Health, Case Western Reserve University, and Farmingdale State College (SUNY); and Honorary Fellowships from King's College London - Dental Institute and the International College of Dentists.

Stan and Marion Bergman and their family are active supporters of organizations fostering the arts, higher education, cultural diversity, and grassroots health care and sustainable entrepreneurial economic development initiatives in the United States, Africa, and other developing regions of the world.

Mr. Bergman is a graduate of The University of the Witwatersrand in South Africa, and is a South African Chartered Accountant and a NYS Certified Public Accountant.

Twitter - @HenrySchein

Episodes: 1/2/2018 @12:00 PM, 10/17/2017 @12:00 PM


Bernard Tyson
Bernard Tyson

CEO, Chairman
Kaiser Permanente
https://share.kaiserpermanente.org/

Bernard J. Tyson is the chairman and CEO of Kaiser Foundation Health Plan, Inc. and Hospitals — known as Kaiser Permanente, one of America’s leading integrated health care providers and not-for-profit health plans. With annual operating revenue of nearly $65 billion, Kaiser Permanente serves 11.8 million members in eight states and the District of Columbia.

Tyson assumed the role of chairman in January 2014 and has served as CEO since 2013. His career at Kaiser Permanente has spanned more than 30 years. During that time, Tyson has successfully managed all major aspects of the organization, serving in roles from hospital administrator to division president to president and chief operating officer of the Oakland, California-based health care organization.

Under Tyson’s leadership, Kaiser Permanente continues to focus on providing affordable, accessible, high-quality health care and improving the health of its members and communities. The organization is delivering on its “T(Show Full Bio)hrive” promise by bringing an industry-leading 21st-century approach to health care and coverage that is helping members achieve their aspirations of total health — physical health as well as mental health and wellness. Kaiser Permanente’s 207,805 employees and 21,275 physicians (with Permanente Medical Groups) provide personalized, coordinated and technologically advanced care that consistently delivers some of the best clinical outcomes in the nation, while also leading the country in prevention, patient safety and quality.

Tyson believes Kaiser Permanente’s combination of prevention, innovation and integration can serve as the model for health care in America. He is dedicated to leading Kaiser Permanente and the health care industry to deliver greater affordability and accessibility to high-quality care for members, consumers, employers and government agencies. He has also been a strong advocate for eliminating health care disparities among individuals by promoting the use of aggregated data from members’ electronic health records to determine the most effective treatments for optimal clinical outcomes.

Tyson’s influence has been felt both nationally and internationally. Modern Healthcare has named him the most influential health care executive for four consecutive years. He is No. 4 on the 2017 list, following Sens. Susan Collins, John McCain and Lisa Murkowski, who were named to the No. 1 spot collectively. In April 2017, he was included on the TIME 100 list of the most influential people in the world.

A San Francisco Bay Area native, Tyson earned a master’s of business degree in health service administration and a bachelor’s degree in health service management from Golden Gate University in San Francisco. He also earned a leadership certificate from Harvard University. Tyson serves on the boards of directors of the American Heart Association. He is vice chair of America’s Health Insurance Plans’ board of directors, a deputy chairman of the International Federation of Health Plans, and is a steward of the World Economic Forum’s Global Challenge on the Future of Health. Tyson is chair of the Bay Area Council, a business-led public policy organization advocating for a strong economy and better quality of life for Bay Area residents.

Twitter - @bernardjtyson

Episodes: 12/26/2017 @12:00 PM, 9/26/2017 @12:00 PM


John Whitman
John Whitman

Adjuct Faculty Member; MBA Health and Management Program
The Wharton School
https://www.google.com/search?q=wharton+Whitman&ie=utf-8&oe=utf-8

John Whitman is a graduate of the University of Pennsylvania’s Wharton MBA Health Care Management Program with a specialization in aging and long-term care. John has dedicated his 30 years of professional work to improving care for one of our nation’s most precious resources…. Our seniors! During that time, John developed a nationally respected consulting company focused totally on care of the elderly in all settings and preaching the smooth transition of patients along the continuum to assure the best level of care, at the right time in the patients recovery and at the best cost to the system. John knowledge and understanding of the flow of senior patients from hospital, to post acute, to long term care and/or back into the community works and how to optimize that process for the good of the patient and for the economical well being of the organizations involved in that process.

John has worked with literally hundreds of hospitals and health care systems in developing various p(Show Full Bio)ost acute strategies, implementing programs in demand, coordinating and refining existing programs and services and promoting better quality of care for seniors while doing so in a way that is economically viable and sustainable for the hospitals and health care systems involved.

John has been a faculty member at The Wharton School’s MBA Health and Management Program for the past 30 years and serves as a board member on the Philadelphia Corporation for Aging.

Fourteen years ago, John founded and is the executive director of The TRECS Institute, a non-profit dedicated to serving as a catalyst to bring about positive changes in the care of our nations seniors.

TRECS is currently coordinating a CMS study in Florida evaluating the ability of reducing avoidable SNF to hospital admissions and readmissions through the use of telemedicine that brings the physician to the residents bed side during evenings, nights, weekends and holidays.

Episodes: 12/19/2017 @12:00 PM, 9/19/2017 @12:00 PM, 2/21/2017 @12:00 PM, 11/10/2015 @12:00 PM


Dr. Carrie Kovarik
Dr. Carrie Kovarik

Associate Professor of Dermatology and Medicine
University of Pennsylvania
http://www.med.upenn.edu/apps/faculty/index.php/g275/p8128402

Carrie L. Kovarik, MD is an Associate Professor of Dermatology, Dermatopathology, and Infectious Diseases at the University of Pennsylvania. Dr. Kovarik has a special interest in global and community health, telemedicine, informatics, and HIV-related skin disease. She created the Penn Dermatology Global Health program, through which she works to provide clinical care and education in developing countries and underserved communities in the United States. Dr. Kovarik is the Head of Dermatology, Informatics, and Telemedicine for the Botswana-UPenn Partnership and has created a global telemedicine consult service which is a collaborative effort between Ministries of Health, local telecommunication and software companies, universities, specialty organizations, numerous countries, and local governments. She is now focusing on developing, sustaining, and researching new models of health care that can increase access to care through telemedicine. She has publ ished over 120 peer reviewed journ(Show Full Bio)al articles, including many studies on the use of mobile technology in health care and the quality of direct to patient telemedicine in the United States. Dr. Kovarik has also been involved in significant advocacy efforts at the state and national levels, with successful implementation of telemedicine bills and payer parternships. She has been the Chair of the Telemedicine Task Force for the American Academy of Dermatology, and she was the Director of the AAD's volunteer teledermatology platform, Accessderm.

Twitter - @carriekovarik

Episodes: 12/19/2017 @12:00 PM, 9/19/2017 @12:00 PM


Dr. Monika Roots
Dr. Monika Roots

VP of Health Services and Senior Medical Director of Behavioral Health; Adjunct Assistant Professor, Psychiatry (University of Wisconsin); Physician Utilization Reviewer (Prest & Associates)
Teladoc
http://www.teladoc.com

Dr. Monika Roots is vice president of health services and senior medical director of Behavioral Health for Teladoc. She is responsible for ensuring the high-quality clinical standards of Teladoc’s comprehensive tele-behavioral services.

Dr. Roots believes in a multidisciplinary treatment approach to mental health which takes into account the individual’s cultural, biological, psychological, and social needs. Her interest in a multisystem approach to mental health led to her previous position as chief Medical Officer of CogCubed focused on assessing and training cognitive processes through games used on new and innovative technologies. She has also practiced in a variety of settings including schools, community outreach programs, and medical/physical rehabilitation units.

Her work has been featured at several national conferences, in addition to multiple journals including Clinical Psychiatry News, Boston Globe, Health 2.0, Techdot MN and Modern Physician. Dr. Roots is al(Show Full Bio)so an adjunct professor at University of Wisconsin-Madison and a physician utilization reviewer for several large insurers. She is a graduate of Carleton College, received her M.D. from University of Sint Eustatius, and then completed her adult psychiatry residency at the University of Minnesota. She then went on to complete a fellowship in child/adolescent psychiatry, also at the University of Minnesota.

Episodes: 12/19/2017 @12:00 PM, 9/19/2017 @12:00 PM


David Baiada
David Baiada

CEO; Pediatric Practice President
BAYADA Home Health Care
http://www.bayada.com

David L. Baiada is the CEO of BAYADA Home Health Care, a global leader in home health care serving clients from more than 335 offices in 22 states with locations in Germany, India, Ireland, and South Korea. Mr. Baiada was appointed CEO in August 2017 when BAYADA’s founder, Mark Baiada, stepped into a new role as Chairman. That milestone was also the official launch of BAYADA’s transformation into a nonprofit organization—putting mission over money—to help ensure that the company will never be sold, and that its mission, vision, beliefs, and values—codified in The BAYADA Way—will endure for generations to come.

Mr. Baiada is committed to a people-first philosophy, attracting and supporting like-minded and like-hearted individuals who share a passion for helping others and put the needs of their clients first. He believes that a choice to pursue a health professional is a choice to help others, and that home is the best place to tune into people’s needs and truly make a differen(Show Full Bio)ce.

Since joining BAYADA in 2002, Mr. Baiada has worked in a variety of roles and learned the business from the ground-up. Taking on progressively increasing responsibilities, he most recently served as practice president for home health, hospice, pediatrics practices; lead the Enterprise Quality teams responsible for policy development, regulatory support, and quality assurance/auditing; spearheaded the redesign of the quality improvement and standards framework for the entire enterprise, including the migration to a world-class technology platform for standards documentation, audit management, and regulatory oversight; oversaw four strategic business acquisitions; and launched the Hospice Specialty Practice to provide high-quality, end-of-life services.

Mr. Baiada shares his commitment to providing compassionate care in the home with his desire to give back to the community. He serves on the board of Settlement Music School in Camden, NJ; heads the Advisory Council at Moorestown Friends School in Moorestown, NJ; serves on the Advisory Board of Drexel University Institute for Entrepreneurship in Philadelphia; has volunteered with Ronald McDonald House; and served as a tutor for the International Center of New York City. In addition, Mr. Baiada is a founding member of the Wharton Family Business Club and a participant in the Wharton Global Family Alliance. He also served as a participant in the Leadership Conference of the New York Association of Healthcare Providers.

In May 2016, Mr. Baiada was named one of the 40 most influential professionals under age 40 in the Philadelphia region by the Philadelphia Business Journal.

Prior to joining BAYADA, Mr. Baiada worked as an analyst and associate at Diamond Management and Technology Partners in Chicago. He earned an MBA in Health Care Management from the Wharton School at the University of Pennsylvania and BA in Economics from Cornell University.

Twitter - @dbayada

Episode: 12/12/2017 @12:00 PM


Thomas Tsai
Thomas Tsai

Chief Resident in Surgery
Brigham and Women's Hospital
https://scholar.harvard.edu/ttsai

Thomas C. Tsai, MD, MPH is currently a chief resident in surgery at Brigham and Women’s Hospital and a research associate in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health. From 2014-2015, he served as a senior advisor to the Assistant Secretary for Planning and Evaluation in the US Department of Health and Human Services.

His current research focuses on the effectiveness and unintended consequences of health policy interventions on the affordability, accessibility, and quality of health care in the United States. His work has been published in The New England Journal of Medicine, JAMA, and Health Affairs.

Dr. Tsai is a graduate of Harvard College. He received a MD from Stanford University School of Medicine and a MPH from the Harvard T.H. Chan School of Public Health.

Episodes: 12/5/2017 @12:00 PM, 5/31/2016 @12:00 PM


Michael Peregrine
Michael Peregrine

Partner
McDermott Will & Emery
http://mwe.com

Michael W. Peregrine represents corporations (and their officers and directors) in connection with governance, corporate structure, fiduciary duties, officer-director liability issues, charitable trust law and corporate alliances. Michael is recognized as one of the leading national practitioners in corporate governance law.

Michael is outside governance counsel to many prominent corporations, including hospitals and health systems, voluntary health organizations, social service agencies, colleges and universities, and health insurance companies. Clients seek Michael’s counsel on matters relating to board conduct, structure, effectiveness, composition and controversy, as well as on internal and external/regulatory challenges to governance. He serves frequently as special counsel in connection with confidential internal board reviews and investigations. He regularly advises boards on complex business transactions, including more than 125 change-of-control transactions in his 37-y(Show Full Bio)ear career.

Recently, Michael has served as lead transaction counsel in connection with a series of nationally prominent combinations of religious-sponsored health systems and large regional health systems/academic medical centers.

Michael is well known as a thought leader in corporate governance. He authors monthly columns on corporate governance for Corporate Counsel magazine and for publications of The Governance Institute. He is a regular contributor on corporate governance topics to The New York Times’ “Deal Book” feature; Corporate Board Member, The Chronicle of Philanthropy; The Harvard Law School Forum on Corporate Governance and Financial Regulation; The Columbia Law School's Blog on Corporations and the Capital Markets, and the New York University School of Law Compliance and Enforcement Forum.

Michael is noted for his extensive experience advising nonprofit corporations on matters of corporate law and governance. He authors a monthly publication, "Corporate Law and Governance Newsletter," and moderates a monthly director education podcast, "Governing Health."

Michael is a co-author of the three corporate governance compliance white papers published jointly by the Office of Inspector General (Department of Health and Human Services) and the American Health Lawyers Association.

Representation of corporations and their governing boards in matters such as:
• Alliances and conversions
• Multi-corporate system restructurings
• Governance reorganizations and bylaw restatements
• Conflicts of interest review and resolution
• Response to Congressional investigations and inquiries
• Response to state and federal governance examinations, audits and litigation
• The board’s fiduciary duty in complex business transactions
• Counsel to board committees (e.g., governance, investment, audit/compliance, executive compensation, search)
• Resolution of disputes regarding intra-system fiduciary obligations
• Disputes with chapters, affiliates and divisions
• Compliance with the Uniform Management of Institutional Funds Act (UMIFA) / Uniform Prudent Management of Institutional Funds Act (UPMIFA)
• Disputes regarding application of funds held in charitable trust
• Roles and responsibilities of chief compliance officer and general counsel
• Board compliance plan oversight obligations
• Effectiveness of organizational compliance programs
• Independent board investigative counsel regarding suspected breach of fiduciary duty or fraud
• Structural measures to increase board efficiency

RESULTS
• Transaction counsel for the combination of St. Joseph Health System and Providence Health & Services (2016)
• Outside counsel to Hackensack University Health Network in connection with its consolidation with Meridian Health System (2016)
• Outside counsel to Hackensack University Health Network in connection with its affiliation with Palisades Healthcare Systems, Inc. (2016)
• Outside counsel for Sylvania Franciscan Health in its corporate combination with Catholic Health Initiatives (2014)
• Transaction counsel for consolidation of St. Joseph Health System and Hoag Memorial Hospital Presbyterian (2013)
• Transaction counsel for consolidation of Swedish Health Services and Providence Health & Services System (2012)
• Outside counsel for the corporate reorganization of the American Cancer Society (2012)

RECOGNITION
• American Health Lawyers Association, appointed as a fellow in 2006
• The Legal 500 US 2015 to 2017
• The Best Lawyers in America, 1993 to 2018, Health Care Law
• The BTI Client Service All Star Team for Law Firms, recognized three times (most recently in 2016) as a Client Service All-Star
• Chambers USA, 2015 to 2017, characterized by clients as "a thought leader,” recognized as a “nationally prominent healthcare attorney, noted for his transactional capabilities and advice concerning governance issues,” and praised for his client service, including his responsiveness and his excellent work product

CREDENTIALS
Education
• Northwestern University School of Law, JD, 1980
• Texas Christian University, BA, 1977
Admissions
• Illinois


MW&E Blog - https://www.mwe.com/en/team/p/peregrine-michael-w?currenttab=thought-leadership¤tview=Publications

Episode: 12/5/2017 @12:00 PM


Dr. Jonathan Kalodimos
Dr. Jonathan Kalodimos

Assistant Professor
Oregon State University - College of Business
http://business.oregonstate.edu/users/jonathan-kalodimos

Jonathan Kalodimos, Ph.D., is an assistant professor of finance at the Oregon State University College of Business. Prior to joining the faculty at OSU, Dr. Kalodimos was a financial economist at the U.S. Securities and Exchange Commission, where he was lead economist on Dodd Frank Act Section 954, which deals with executive compensation clawbacks. His research on corporate governance and financial market regulation has received numerous citations in the popular press, including the Wall Street Journal, the New York Times, the Financial Times, NPR, Bloomberg and the Harvard Business Review. Dr. Kalodimos completed a Ph.D. in finance at the University of Washington’s Michael G. Foster School of Business in 2014, one year after earning a Master of Science in business administration from the same school. He also holds an MS in finance from the University of Florida’s Hough Graduate School of Business and a Bachelor of Science in physics from Kansas State University. From 2007 to 2009, Dr.(Show Full Bio) Kalodimos was a real estate capital markets analyst for Wachovia Bank.

Personal Site - http://jonathankalodimos.com/

Episode: 12/5/2017 @12:00 PM